Craneware (FRA:3X6) Moat Score: 5/10 (As of Jul. 11, 2026)


FRA:3X6 Craneware PLC FRA:3X6
83 GF Score
Price €13.50
GF Value €24.40
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Craneware Moat Score?

Craneware FRA:3X6 +7.14% 83 Moat Score is 5 as of Jul. 11, 2026. GuruFocus rates FRA:3X6 with a GF Score™ of 83/100 and a GF Value™ of €24.40 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 677 Healthcare Providers & Services companies, Craneware ranks better than 96.01% on this metric.

Craneware has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Craneware has Narrow Moat: Craneware has a solid position in healthcare software with moderate customer switching costs and some intellectual property. However, it lacks the scale and brand strength to achieve a wide moat, and its pricing power is limited by competition.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Craneware might have Narrow Moat - Solid narrow moat.

Craneware  (FRA:3X6) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Craneware Moat Score Related Terms

FRA:3X6 vs VEEV, BTSG, TEM: Moat Score Comparison

For the Health Information Services subindustry, Craneware's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Craneware Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Craneware's Moat Score distribution charts can be found below:

* The bar in red indicates where Craneware's Moat Score falls into.


FRA:3X6
83GF Score
Craneware PLC FRA:3X6
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Craneware (FRA:3X6) has a Moat Score of 5 as of Jul. 11, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Craneware ranks #27 out of 677 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is Craneware's Moat Score too high?
Craneware's current Moat Score is 5. Based on the distribution chart, Craneware ranks #27 out of 677 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Craneware has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Craneware's Moat Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Craneware ranks #27 out of 677 companies for Moat Score. This places Craneware in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Craneware's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Craneware stock overvalued right now?
Based on GuruFocus' analysis, Craneware (FRA:3X6) is currently considered Significantly Undervalued. The stock's GF Value™ is €24.40, compared to a current price of €13.50 — trading 44.7% below its estimated fair value. The current Moat Score is 5. Craneware's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Craneware (FRA:3X6), the current Moat Score is 5 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Craneware (FRA:3X6) Overvalued in 2026?

Based on GuruFocus' analysis, Craneware stock appears to be undervalued. The current stock price of €13.50 is trading 44.7% below its estimated GF Value™ of €24.40. GuruFocus considers Craneware to be Significantly Undervalued.

Key valuation signals for FRA:3X6:

  • Moat Score: 5
  • GF Value™: €24.40 vs. price of €13.50 (44.7% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the FRA:3X6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Craneware Business Description

Other Exchanges CRWl:UKCRW:UK
Address 1 Tanfield, Edinburgh, GBR, EH3 5DA
Craneware PLC provides automated revenue integrity solutions that improve financial performance for healthcare organizations. Its activities include the development, licensing, and ongoing support of computer software for the US healthcare industry. It is engaged in the sale of software licenses, white labelling, and professional services (including installation) to hospitals within the USA. The company recognizes its revenues from the sale of and distribution agreements relating to software licenses and professional services.
83GF Score

Get the complete analysis for FRA:3X6

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.50
Price
€24.40
GF Value